9/20/24 18:01 | 9/19/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S | 0 | 2.79 | 0 | 0 | 0 | 35 | D | | | | | | | | | | | | | | |
9/18/24 16:30 | 9/16/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S | -1 | 2.80 | 0 | 0 | -1 | 35 | D | | | | | | | | | | | | | | |
6/20/24 20:29 | 6/17/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.dm | -1 | 3.40 | 0 | 0 | -1 | 35 | D | | | | | | | | | | | | | | |
3/20/24 17:36 | 3/18/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -4 | 10.61 | 0 | 0 | -1 | 27 | D | | | | | | | | | | | | | | |
2/7/24 16:00 | 2/6/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S | -126 | 13.70 | 0 | -9 | -25 | 28 | D | | | | | | | | | | | | | | |
1/17/24 16:00 | 1/12/24 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S | -101 | 10.95 | 0 | -9 | -20 | 37 | D | | | | | | | | | | | | | | |
12/20/23 16:03 | 12/18/23 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -3 | 7.67 | 0 | 0 | -1 | 46 | D | | | | | | | | | | | | | | |
9/20/23 16:15 | 9/18/23 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -4 | 9.89 | 0 | 0 | -1 | 47 | D | | | | | | | | | | | | | | |
6/21/23 16:24 | 6/16/23 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -4 | 10.04 | 0 | 0 | -1 | 47 | D | | | | | | | | | | | | | | |
3/20/23 16:59 | 3/16/23 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -2 | 0.4094 | 0 | -5 | -1 | 569 | D | | | | | | | | | | | | | | |
12/20/22 16:09 | 12/16/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | D | | S.m | -5 | 0.3969 | 0 | -14 | -2 | 575 | D | | | | | | | | | | | | | | |
9/21/22 16:06 | 9/19/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -2 | 1.13 | 0 | -1 | 0 | 589 | D | | | | | | | | | | | | | | |
6/22/22 16:05 | 6/21/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -2 | 1.14 | 0 | -1 | 0 | 590 | D | | | | | | | | | | | | | | |
5/17/22 16:05 | 5/16/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -17 | 1.03 | 0 | -17 | -3 | 591 | D | | | | | | | | | | | | | | |
3/23/22 16:01 | 3/21/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -2 | 1.27 | 0 | -1 | 0 | 558 | D | | | | | | | | | | | | | | |
1/5/22 16:02 | 1/3/22 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -40 | 2.05 | 0 | -20 | -3 | 559 | D | | | | | | | | | | | | | | |
12/22/21 16:01 | 12/20/21 | VSTM | Verastem, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | MA | O | CFO | S | -12 | 2.27 | 0 | -5 | -1 | 579 | D | | | | | | | | | | | | | | |
8/30/18 16:04 | 8/29/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S | -51 | 5.77 | 0 | -9 | -3 | 321 | D | | | | | | | | | | | | | | |
8/9/18 16:20 | 8/7/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | M.d | 420 | 4.80 | 0 | 88 | 33 | 349 | D | | | | | | | | | | | | | | |
8/9/18 16:20 | 8/7/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S.d | -608 | 6.08 | 0 | -100 | -22 | 349 | D | | | | | | | | | | | | | | |
7/31/18 16:08 | 7/27/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | M.d | 212 | 4.23 | 0 | 50 | 16 | 362 | D | | | | | | | | | | | | | | |
7/31/18 16:08 | 7/27/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S.d | -346 | 5.54 | 0 | -63 | -15 | 362 | D | | | | | | | | | | | | | | |
7/26/18 19:13 | 7/24/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S | -29 | 5.25 | 0 | -6 | -1 | 374 | D | | | | | | | | | | | | | | |
7/23/18 16:54 | 7/19/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S.m | -13 | 5.25 | 0 | -3 | -1 | 380 | D | | | | | | | | | | | | | | |
7/16/18 17:10 | 7/12/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | M.d | 24 | 4.12 | 0 | 6 | 2 | 382 | D | | | | | | | | | | | | | | |
7/16/18 17:10 | 7/12/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S.dm | -54 | 5.25 | 0 | -10 | -3 | 382 | D | | | | | | | | | | | | | | |
7/11/18 21:45 | 7/9/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | M.dm | 611 | 4.24 | 0 | 144 | 59 | 387 | D | | | | | | | | | | | | | | |
7/11/18 21:45 | 7/9/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S.dm | -890 | 5.26 | 0 | -169 | -30 | 387 | D | | | | | | | | | | | | | | |
3/12/18 17:23 | 3/7/18 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | S | -449 | 4.62 | 0 | -97 | -21 | 358 | D | | | | | | | | | | | | | | |
5/30/17 20:46 | 5/26/17 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | P | 2 | 2.33 | 0 | 1 | 0 | 475 | D | | | | | | | | | | | | | | |
11/3/16 16:11 | 11/2/16 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | P.m | 58 | 2.34 | 0 | 25 | 10 | 268 | D | -51 | -26 | -20 | -18 | -19 | -11 | -8 | -2 | 4 | 9 | 4 | 35 | 4 | |
11/16/15 16:15 | 11/12/15 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | P | 4 | 2.93 | 1 | 2 | 2 | 68 | D | -29 | -38 | -44 | -35 | -25 | -15 | -5 | -3 | -4 | 1 | 11 | -5 | 8 | -13 |
11/9/15 20:20 | 11/9/15 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | P | 9 | 3.08 | 1 | 3 | 5 | 66 | D | -24 | -32 | -39 | -32 | -16 | -18 | -15 | 2 | 0 | -2 | 6 | -7 | -1 | -21 |
6/16/14 16:32 | 6/16/14 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Gagnon Robert E. | MA | O | CFO | P | 19 | 3.86 | 0 | 5 | New | 5 | D | 36 | 2 | -16 | -16 | -7 | -8 | -4 | -6 | 1 | 0 | 24 | 14 | 25 | 36 |
3/1/12 15:23 | 2/28/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | VP,Finan | S.m | -179 | 115.25 | 33 | -2 | -28 | 4 | D | 103 | 66 | 24 | 5 | -1 | -3 | 0 | 0 | 2 | 0 | 9 | 12 | 26 | 46 |
2/27/12 16:18 | 2/23/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | VP,Finan | M.dm | 52 | 22.98 | 33 | 2 | 70 | 6 | D | 112 | 73 | 26 | 3 | 0 | -5 | -3 | 1 | 0 | 2 | 8 | 13 | 25 | 43 |
2/27/12 16:18 | 2/24/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | VP,Finan | S.d | -122 | 115.53 | 33 | -1 | -16 | 6 | D | 112 | 73 | 26 | 3 | 0 | -5 | -3 | 1 | 0 | 2 | 8 | 13 | 25 | 43 |
2/16/12 14:37 | 2/14/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | VP,Finan | S | -66 | 118.61 | 33 | -1 | -10 | 5 | D | 111 | 77 | 30 | 4 | 4 | 1 | -3 | 0 | 1 | -2 | 1 | 15 | 24 | 41 |
2/13/12 16:27 | 2/9/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | VP,Finan | M.d | 0 | 0.00 | 33 | 1 | 18 | 6 | D | 112 | 78 | 34 | 6 | 7 | 2 | -3 | -3 | 0 | -3 | 2 | 14 | 22 | 39 |
12/8/11 14:05 | 12/6/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -89 | 112.31 | 33 | -1 | -14 | 5 | D | 133 | 66 | 19 | 22 | -4 | 1 | 1 | -1 | -2 | -2 | 3 | 8 | 19 | 37 |
11/14/11 11:26 | 11/9/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -89 | 112.04 | 33 | -1 | -11 | 6 | D | 144 | 76 | 18 | 24 | 27 | 4 | 0 | 0 | 1 | -5 | -3 | 6 | 21 | 20 |
10/7/11 13:48 | 10/5/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -25 | 97.66 | 33 | 0 | -3 | 7 | D | 102 | 74 | 36 | -7 | 10 | -1 | 3 | 12 | 1 | 2 | 14 | 16 | 27 | 53 |
10/4/11 18:28 | 10/3/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | M.d | 39 | 49.59 | 33 | 1 | 11 | 8 | D | 82 | 57 | 21 | -18 | -1 | -6 | -6 | -6 | 8 | 10 | 25 | 25 | 42 | 65 |
10/4/11 18:28 | 10/3/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S.d | -72 | 92.55 | 33 | -1 | -9 | 8 | D | 82 | 57 | 21 | -18 | -1 | -6 | -6 | -6 | 8 | 10 | 25 | 25 | 42 | 65 |
5/9/11 16:38 | 5/6/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -93 | 96.13 | 33 | -1 | -11 | 8 | D | 104 | 91 | 54 | 46 | 35 | 16 | -3 | -2 | -1 | -2 | -5 | -5 | 17 | 36 |
5/4/11 14:53 | 5/4/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -21 | 96.03 | 33 | 0 | -2 | 9 | D | 110 | 87 | 57 | 50 | 40 | 25 | -2 | -1 | -2 | -1 | -3 | 2 | 19 | 38 |
3/3/11 15:08 | 3/2/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -98 | 70.02 | 33 | -1 | -13 | 9 | D | 57 | 23 | 30 | 9 | 6 | 6 | 3 | 3 | 2 | 2 | 5 | 33 | 34 | 70 |
2/25/11 15:54 | 2/23/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | M.dm | 52 | 25.40 | 33 | 2 | 22 | 11 | D | 33 | 23 | 21 | 5 | 0 | 3 | 0 | -1 | 1 | 6 | 6 | 39 | 37 | 73 |
2/25/11 15:54 | 2/24/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S.d | -71 | 66.99 | 33 | -1 | -9 | 11 | D | 33 | 23 | 21 | 5 | 0 | 3 | 0 | -1 | 1 | 6 | 6 | 39 | 37 | 73 |
2/18/11 15:09 | 2/17/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -49 | 67.10 | 33 | -1 | -6 | 11 | D | 33 | 20 | 23 | 5 | 1 | 4 | 2 | 1 | 0 | 0 | 3 | 43 | 31 | 72 |
1/5/11 14:45 | 1/4/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S.d | -340 | 66.57 | 33 | -5 | -32 | 11 | D | 40 | 24 | 33 | 15 | 2 | 1 | -1 | -1 | 0 | 3 | -1 | 10 | 62 | 71 |
1/5/11 14:45 | 1/4/11 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | M.d | 198 | 46.07 | 33 | 4 | 66 | 11 | D | 40 | 24 | 33 | 15 | 2 | 1 | -1 | -1 | 0 | 3 | -1 | 10 | 62 | 71 |
12/7/10 17:14 | 12/6/10 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gagnon Robert E. | MA | O | Chief Ac | S | -53 | 66.53 | 33 | -1 | -6 | 12 | D | 60 | 38 | 42 | 19 | 11 | 2 | 2 | 2 | 0 | -2 | -1 | 7 | 39 | 67 |